Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 47

    1.

    Incidence and predictors of silent myocardial infarction in type 2 diabetes and the effect of fenofibrate: an analysis from the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study.

    Burgess DC, Hunt D, Li L, Zannino D, Williamson E, Davis TM, Laakso M, Kesäniemi YA, Zhang J, Sy RW, Lehto S, Mann S, Keech AC.

    Eur Heart J. 2009 Sep 29. [Epub ahead of print]PMID: 19797259 [PubMed - as supplied by publisher]Related articles

    2.

    Effect of fenofibrate on amputation events in people with type 2 diabetes mellitus (FIELD study): a prespecified analysis of a randomised controlled trial.

    Rajamani K, Colman PG, Li LP, Best JD, Voysey M, D'Emden MC, Laakso M, Baker JR, Keech AC; FIELD study investigators.

    Lancet. 2009 May 23;373(9677):1780-8.PMID: 19465233 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Relationships of HDL cholesterol, ApoA-I, and ApoA-II with homocysteine and creatinine in patients with type 2 diabetes treated with fenofibrate.

    Taskinen MR, Sullivan DR, Ehnholm C, Whiting M, Zannino D, Simes RJ, Keech AC, Barter PJ; FIELD study investigators.

    Arterioscler Thromb Vasc Biol. 2009 Jun;29(6):950-5. Epub 2009 Mar 26.PMID: 19325138 [PubMed - indexed for MEDLINE]Related articles

    4.

    Using the EQ-5D index score as a predictor of outcomes in patients with type 2 diabetes.

    Clarke PM, Hayes AJ, Glasziou PG, Scott R, Simes J, Keech AC.

    Med Care. 2009 Jan;47(1):61-8.PMID: 19106732 [PubMed - indexed for MEDLINE]Related articles

    5.

    Long-term effects of fenofibrate on carotid intima-media thickness and augmentation index in subjects with type 2 diabetes mellitus.

    Hiukka A, Westerbacka J, Leinonen ES, Watanabe H, Wiklund O, Hulten LM, Salonen JT, Tuomainen TP, Yki-Järvinen H, Keech AC, Taskinen MR.

    J Am Coll Cardiol. 2008 Dec 16;52(25):2190-7.PMID: 19095138 [PubMed - indexed for MEDLINE]Related articles

    6.

    Can self-rated health scores be used for risk prediction in patients with type 2 diabetes?

    Hayes AJ, Clarke PM, Glasziou PG, Simes RJ, Drury PL, Keech AC.

    Diabetes Care. 2008 Apr;31(4):795-7. Epub 2008 Jan 9.PMID: 18184900 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Effect of fenofibrate on the need for laser treatment for diabetic retinopathy (FIELD study): a randomised controlled trial.

    Keech AC, Mitchell P, Summanen PA, O'Day J, Davis TM, Moffitt MS, Taskinen MR, Simes RJ, Tse D, Williamson E, Merrifield A, Laatikainen LT, d'Emden MC, Crimet DC, O'Connell RL, Colman PG; FIELD study investigators.

    Lancet. 2007 Nov 17;370(9600):1687-97. Epub 2007 Nov 7.PMID: 17988728 [PubMed - indexed for MEDLINE]Related articles

    8.

    Long-term effects of fenofibrate on VLDL and HDL subspecies in participants with type 2 diabetes mellitus.

    Hiukka A, Leinonen E, Jauhiainen M, Sundvall J, Ehnholm C, Keech AC, Taskinen MR.

    Diabetologia. 2007 Oct;50(10):2067-75. Epub 2007 Jul 26. Erratum in: Diabetologia. 2007 Dec;50(12):2611-3. PMID: 17653691 [PubMed - indexed for MEDLINE]Related articles

    9.

    Putting results of a clinical trial into perspective.

    Wilcken NR, Gebski VJ, Pike R, Keech AC.

    Med J Aust. 2007 Apr 2;186(7):368-70. No abstract available. PMID: 17407436 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Interpreting the results of a clinical trial.

    Keech AC, Pike R, Granger RE, Gebski VJ.

    Med J Aust. 2007 Mar 19;186(6):318-9. Review. No abstract available. PMID: 17371216 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Micronized fenofibrate: a useful choice for the correction of dyslipidemia in metabolic syndrome and Type 2 diabetes.

    Grieve SM, Ansquer JC, Keech AC.

    Future Cardiol. 2006 Nov;2(6):635-46.PMID: 19804254 [PubMed - in process]

    12.

    Interventions for prevention of post-operative atrial fibrillation and its complications after cardiac surgery: a meta-analysis.

    Burgess DC, Kilborn MJ, Keech AC.

    Eur Heart J. 2006 Dec;27(23):2846-57. Epub 2006 Oct 2.PMID: 17015402 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Asia-Pacific collaboration on coronary heart disease risk factor intervention: study design and methods.

    Ritchie GM, Keech AC; ASPAC Collaborative Group.

    Heart Lung Circ. 2001;10(1):24-9.PMID: 16352021 [PubMed]Related articles

    14.

    Cost-effectiveness of rehabilitation after an acute coronary event: a randomised controlled trial.

    Briffa TG, Eckermann SD, Griffiths AD, Harris PJ, Heath MR, Freedman SB, Donaldson LT, Briffa NK, Keech AC.

    Med J Aust. 2005 Nov 7;183(9):450-5.PMID: 16274344 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Urinary albumin levels in the normal range determine arterial wall thickness in adults with Type 2 diabetes: a FIELD substudy.

    Keech AC, Grieve SM, Patel A, Griffiths K, Skilton M, Watts GF, Marwick TH, Groshens M, Celermajer DS.

    Diabet Med. 2005 Nov;22(11):1558-65.PMID: 16241922 [PubMed - indexed for MEDLINE]Related articles

    16.

    An evidence based clinical aid for cardiovascular disease--what do GPs think?

    Mcavoy BR, Fulcher GR, Amerena JV, Conner GW, Beltrame JF, Hankey GJ, Keech AC, Lloyd BL, Neale ML, Pollock CA, Sudhir K, Waltham RD, West MJ; Practical Implementation Taskforce for the Prevention of Cardiovascular Disease.

    Aust Fam Physician. 2005 Apr;34(4):297-8. No abstract available. PMID: 15861759 [PubMed - indexed for MEDLINE]Related articles

    17.

    New carotid plaque formation is very common in adult patients with Type 2 diabetes mellitus.

    Lundman P, Keech AC, Griffiths K, Pillai A, Celermajer DS.

    Diabet Med. 2005 Mar;22(3):355-6. No abstract available. PMID: 15717891 [PubMed - indexed for MEDLINE]Related articles

    18.

    Allocation concealment and blinding: when ignorance is bliss.

    Forder PM, Gebski VJ, Keech AC.

    Med J Aust. 2005 Jan 17;182(2):87-9. Review. No abstract available. PMID: 15651970 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Generalising the results of trials to clinical practice.

    Seale JP, Gebski VJ, Keech AC.

    Med J Aust. 2004 Nov 15;181(10):558-60. No abstract available. PMID: 15540970 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Multiple analyses in clinical trials: sound science or data dredging?

    Lord SJ, Gebski VJ, Keech AC.

    Med J Aust. 2004 Oct 18;181(8):452-4. Review. No abstract available. PMID: 15487966 [PubMed - indexed for MEDLINE]Related articlesFree article

    21.

    Balancing the outcomes: reporting adverse events.

    Keech AC, Wonders SM, Cook DI, Gebski VJ.

    Med J Aust. 2004 Aug 16;181(4):215-8. No abstract available. PMID: 15310259 [PubMed - indexed for MEDLINE]Related articlesFree article

    22.

    Subgroup analysis: application to individual patient decisions.

    Simes RJ, Gebski VJ, Keech AC.

    Med J Aust. 2004 May 3;180(9):467-9. No abstract available. PMID: 15115428 [PubMed - indexed for MEDLINE]Related articlesFree article

    23.

    Subgroup analysis in clinical trials.

    Cook DI, Gebski VJ, Keech AC.

    Med J Aust. 2004 Mar 15;180(6):289-91. Review. No abstract available. PMID: 15012568 [PubMed - indexed for MEDLINE]Related articlesFree article

    24.

    Making sense of trial results: outcomes and estimation.

    O'Connell RL, Gebski VJ, Keech AC.

    Med J Aust. 2004 Feb 2;180(3):128-30. No abstract available. PMID: 14748677 [PubMed - indexed for MEDLINE]Related articlesFree article

    25.

    Inclusion of patients in clinical trial analysis: the intention-to-treat principle.

    Heritier SR, Gebski VJ, Keech AC.

    Med J Aust. 2003 Oct 20;179(8):438-40. Review. No abstract available. PMID: 14558871 [PubMed - indexed for MEDLINE]Related articlesFree article

    26.

    Baseline data in clinical trials.

    Burgess DC, Gebski VJ, Keech AC.

    Med J Aust. 2003 Jul 21;179(2):105-7. Review. No abstract available. PMID: 12864724 [PubMed - indexed for MEDLINE]Related articlesFree article

    27.

    Recruitment to randomised studies.

    Hague WE, Gebski VJ, Keech AC.

    Med J Aust. 2003 Jun 2;178(11):579-81. No abstract available. PMID: 12765509 [PubMed - indexed for MEDLINE]Related articlesFree article

    28.

    Flow of participants in randomised studies.

    Cakir B, Gebski VJ, Keech AC.

    Med J Aust. 2003 Apr 7;178(7):347-9. No abstract available. PMID: 12670283 [PubMed - indexed for MEDLINE]Related articlesFree article

    29.

    Clinical trials research in the new millennium: the International Clinical Trials Symposium, Sydney, 21-23 October 2002.

    Pike R, Keech AC, Simes RJ.

    Med J Aust. 2003 Apr 7;178(7):316-7. No abstract available. PMID: 12670271 [PubMed - indexed for MEDLINE]Related articlesFree article

    30.

    Statistical methods in clinical trials.

    Gebski VJ, Keech AC.

    Med J Aust. 2003 Feb 17;178(4):182-4. No abstract available. PMID: 12580749 [PubMed - indexed for MEDLINE]Related articlesFree article

    31.

    Randomisation in clinical trials.

    Beller EM, Gebski V, Keech AC.

    Med J Aust. 2002 Nov 18;177(10):565-7. No abstract available. PMID: 12429008 [PubMed - indexed for MEDLINE]Related articlesFree article

    32.

    Managing the resource demands of a large sample size in clinical trials: can you succeed with fewer subjects?

    Keech AC, Gebski V.

    Med J Aust. 2002 Oct 21;177(8):445-7. No abstract available. PMID: 12381256 [PubMed - indexed for MEDLINE]Related articlesFree article

    33.

    Determining the sample size in a clinical trial.

    Kirby A, Gebski V, Keech AC.

    Med J Aust. 2002 Sep 2;177(5):256-7. No abstract available. PMID: 12197821 [PubMed - indexed for MEDLINE]Related articlesFree article

    34.

    Specifying objectives and outcomes for clinical trials.

    Gebski V, Marschner I, Keech AC.

    Med J Aust. 2002 May 20;176(10):491-2. No abstract available. PMID: 12065014 [PubMed - indexed for MEDLINE]Related articlesFree article

    35.

    Specifying interventions in a clinical trial.

    Brighton JK, Gebski VJ, Keech AC.

    Med J Aust. 2002 Mar 18;176(6):281-2. No abstract available. PMID: 11999263 [PubMed - indexed for MEDLINE]Related articlesFree article

    36.

    Selecting participants for clinical trials.

    Keech AC, Gebski VJ.

    Med J Aust. 2001 Nov 5;175(9):490-1. No abstract available. PMID: 11758080 [PubMed - indexed for MEDLINE]Related articles

    37.

    Scientific background and rationale for a randomised controlled trial.

    Ghersi D, Gebski VJ, Keech AC; NHMRC Ckinical Trials Centre, University of Sidney, NSW.

    Med J Aust. 2001 Oct 1;175(7):386. No abstract available. PMID: 11700821 [PubMed - indexed for MEDLINE]Related articles

    38.

    Randomised controlled trials: elements of a good study.

    Gebski VJ, Beller EM, Keech AC.

    Med J Aust. 2001 Sep 3;175(5):272-4. No abstract available. PMID: 11587262 [PubMed - indexed for MEDLINE]Related articles

    39.

    Hemorrhagic complications of intravenous heparin use.

    Juergens CP, Semsarian C, Keech AC, Beller EM, Harris PJ.

    Am J Cardiol. 1997 Jul 15;80(2):150-4.PMID: 9230150 [PubMed - indexed for MEDLINE]Related articles

    40.

    Hormone replacement therapy is associated with improved arterial physiology in healthy post-menopausal women.

    McCrohon JA, Adams MR, McCredie RJ, Robinson J, Pike A, Abbey M, Keech AC, Celermajer DS.

    Clin Endocrinol (Oxf). 1996 Oct;45(4):435-41.PMID: 8959082 [PubMed - indexed for MEDLINE]Related articles

    41.

    Absence of effects of prolonged simvastatin therapy on nocturnal sleep in a large randomized placebo-controlled study. Oxford Cholesterol Study Group.

    Keech AC, Armitage JM, Wallendszus KR, Lawson A, Hauer AJ, Parish SE, Collins R.

    Br J Clin Pharmacol. 1996 Oct;42(4):483-90.PMID: 8904621 [PubMed - indexed for MEDLINE]Related articlesFree article

    42.

    Absence of effect of simvastatin on the progression of lens opacities in a randomised placebo controlled study. Oxford Cholesterol Study Group.

    Harris ML, Bron AJ, Brown NA, Keech AC, Wallendszus KR, Armitage JM, MacMahon S, Snibson G, Collins R.

    Br J Ophthalmol. 1995 Nov;79(11):996-1002.PMID: 8534671 [PubMed - indexed for MEDLINE]Related articlesFree article

    43.

    Absorption and elimination of bismuth from oral doses of tripotassium dicitrato bismuthate.

    Froomes PR, Wan AT, Keech AC, McNeil JJ, McLean AJ.

    Eur J Clin Pharmacol. 1989;37(5):533-6.PMID: 2598996 [PubMed - indexed for MEDLINE]Related articles

    44.

    An acquired case of aortic coarctation.

    Keech AC, Westlake GW, Wallis PL, Hamer AW.

    Am Heart J. 1988 Jun;115(6):1328-32. No abstract available. PMID: 3376856 [PubMed - indexed for MEDLINE]Related articles

    45.

    Simple extraction of atenolol from urine and its determination by high-performance liquid chromatography.

    Keech AC, Harrison PM, McLean AJ.

    J Chromatogr. 1988 Apr 8;426(1):234-6. No abstract available. PMID: 3384877 [PubMed - indexed for MEDLINE]Related articles

    46.

    Extent and pharmacokinetic mechanisms of oral atenolol-verapamil interaction in man.

    Keech AC, Harper RW, Harrison PM, Pitt A, McLean AJ.

    Eur J Clin Pharmacol. 1988;35(4):363-6.PMID: 3197744 [PubMed - indexed for MEDLINE]Related articles

    47.

    Pharmacokinetic interaction between oral metoprolol and verapamil for angina pectoris.

    Keech AC, Harper RW, Harrison PM, Pitt A, McLean AJ.

    Am J Cardiol. 1986 Sep 1;58(6):551-2. No abstract available. PMID: 3529913 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...